The deal provides a non-dilutive path to monetize dormant IP but offers no near-term cash infusion beyond a capped royalty stream. Monitor for any exercise of the acquisition option, which would restructure FOXO's ownership of its core epigenetics asset.
Price Chart
Executive Summary
FOXO Technologies entered into a Strategic Technology License Agreement with its founder, Jon R. Sabes, and his entity LongevityFP Technologies, granting an exclusive worldwide license to FOXO's epigenetics IP in exchange for a 3% royalty capped at $1.3 million and a ten-year option for the licensee to acquire majority ownership of FOXO Labs. The agreement also includes mutual releases resolving prior matters between the parties.
Key Financial Metrics
Key Facts
- Exclusive worldwide license of FOXO's epigenetics IP to LongevityFP Technologies, controlled by founder Jon R. Sabes
- Royalty of 3% of net revenues from commercialization, capped at $1,300,000
- Ten-year exclusive option for LongevityFP to acquire majority ownership of FOXO Labs (Track A: 100% of FLI for 40% of LongevityFP equity; Track B: 60% of FLI for 40% retained by FOXO)
- FOXO retains ownership of FLI and the Licensed IP throughout the license period
- Agreement includes mutual releases resolving all prior matters between FOXO and Jon R. Sabes
Financial Impact
Royalty capped at $1.3 million; no upfront payment disclosed; potential equity upside from 40% stake in the resulting enterprise if option exercised
Risk Factors
- Royalty cap of $1.3 million limits total cash upside from the license
- Ten-year option creates long-term uncertainty over FOXO's ownership of FOXO Labs
- No upfront payment or minimum royalty guarantees
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-025636 |
| Exhibit: ex10-1.htm | 0001493152-26-025636 |
| Exhibit: ex99-1.htm | 0001493152-26-025636 |
| Document: 0001493152-26-025636-index-headers.html | 0001493152-26-025636 |
| Document: 0001493152-26-025636-index.html | 0001493152-26-025636 |
| Document: 0001493152-26-025636.txt | 0001493152-26-025636 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
May 28, 2026 21w ago | 8-K | — | awaiting T+20 | — | — |
May 22, 2026 22w ago | 8-K | — | awaiting T+20 | — | — |
May 18, 2026 23w ago | 8-K | — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers